Atenolol: ICI's β-blocker has been approved for marketing in the USA as an antianginal agent
1
JFrom Our JFUes Atenolol: ICI's p-blocker has been approved for marketing in the USA as an antianginal agent Therapeutic use Atenolol in the treatment of angina pectoris. Bachmann M. et al. Schweizerische Medizinische Wochenschrift 109: 1857. 1979 Electrocardiographic ischemic threshold after intravenous administration of atenolol in patients with angina of effort. Radice M. et al. Acta Therapeutica 5: 305. 1979 Atenolol: once daily cardioselective beta blockade for angina pectoris. Jackson G. et al. Circulation 61: 555. 1980 Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. Thompson DS. et al. British Heart Journal 43: 668. 1980 Once a day p-adrenoccptor blockade in the management of angina pectoris. Joy M. et al. European Journal of Clinical Investigation 10: 17. 1980 Effects of atenolol on heart rate. blood pressure and exercise tolerance in patients with essential hypertension and effort angina. Okamatsu S. et a!. Acta Therapeutica 6: 325. 1980 Long-term benefit of cardioselective p-blockade with once-daily atenolol therapy in angina pectoris. Schwartz JB et al. American Heart Journal 101: 380. 1981 Effect of long-term administration of atenolol on exercise tolerance in patients with angina or effort. Radice M. et al. International Journal of Clinical Pharmacology Research 2: 119, 1982 Action of nifedipine and atenolol administration in patients suffering from essential hypertension and angina pectoris. Schirripa V, et al. Minerva Medica 73: 3191, 1982 Cardioselectivity and Partial Agonist Activity in the Antianginal Efficacy of the Antagonists. Magnani B. et al. Drugs 25: 166. 1983 Therapeutic Comparison between atenolol and nifedipine in effort angina. Gruppillo P. et al. Drugs 25: 194. 1983 Atenolol in Angina. Boyle RM. et al. Drugs 25: 193, 1983 A comparison of once and twice daily atenolol for angina pectoris. Bo) le RM. et al. International Journal of Cardiology 3: 25. 1983 Improved exercise performance following single daily dose of atenolol in stable angina. Balu V, et al. International Journal of Cardiology 3: 15. 1983 Are 'long-acting nitrates' effective in effort related angina pectoris? O'Neill. D. et al. British Heart Journal49: 619. 1983 Effect of atenolol on treadmill performance in patients with angina pectoris. Kritzer G. et al. Clinical Pharmacy 2: 236. 1983 Combined therapy with verapamil and atenolol in chronic stable angina. Lessem J. Journal of the American College of Cardiology 1: 596. 1983 Atenolol once daily in angina. Makynen P. Ruosteenoja R. V11l World Congress of Cardiology. Tokyo 183. 1978 Atenolol once daily in the treatment of angina pectoris. Majid BA. et al. Vl11 World Congress of Cardiology- Tokyo 182, 1978 The effects of atenolol. given once and twice daily, in patients with angina pectoris. Harry J. et al. V11I World Congress of Cardiology -Tokyo 187. 1978 Effect of atenolol and nitroglycerin ointment on exercise tolerance in patients with coronary heart disease. Koenig W. Diehm C. Deutsche Medizinische Wochenschrift 108: 1798. 1983 The combination of nifedipine and atenolol in angina pectoris. Efficacy and effect on left ventricular function. Findlay I. et al. Circulation 68: 111-53. 1983 The influence of partial agonist activity of beta blockers in treatment of angina pectoris. Quyyumi AA. et al. Circulation 68: 111-54. 1983 Cigarette smoking and the treatment of angina with propranolol. atenolol. and nifedipine. Deanfield J. et al. New England Journal 0156-2703/86/0913-()()19/0$01.00/0 ® ADIS Press of Medicine 31 0: 951. 1984 Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. Quyyumi AA. et al. British Medical Journal 289: 951. 1984 1\tenolol. nadolol. and pindolol in angina pectoris on effort: Effect of pharmacokinetics. Kostis JB. et al. American Heart Journal 108: 1131. 1984 Combined therapy with Ca-antagonists and beta adrenergic receptor blocking agents in chronic stable angina. Lessem J. Acta Medica Scandinavica 83. 1984 Addition of verapamil in the treatment of angina resistant to f:J- adrenoceptor blockers. McGourty JC. et al. British Journal of Clinical Pharmacology I 7: 638P. 1984 Partial agonist activity in beta blockers: The importance of heart rate reduction in treatment of nocturnal angina. Quyyumi AA, et al. European Heart Journal 5: 33. 1984 Combination of nifedipine with atenolol or propranolol in chronic stable angina. de Buitleir M. et al. European Heart Journal 5: 128. 1984 Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. Quyyumi AA. et al. British Medical Journal 289: 951, 1984 Synergistic action of molsidomine and athenolol in patients with exertional angina. Gimeno JV. et al. Medicina Clinica 83: 624. 1984 The treatment of angina pectoris in patients with chronic obstructive airways disease. Findlay IN. et al. British Journal of Clinical Pharmacology 19: I SOP. 1985 Double-blind. randomised. placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol. De Backer GG. Derese A. American Heart Journal 109: 6 78. 1985 Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris. Jee LD. Opie LH. American Journal of Cardiology 56: 551, 1985 Comparison of oxyfedrine and atenolol in angina pectoris - a double- blind study. Fananapazir L. Bray C. British Journal of Clinical Pharmacology 20: 405. 1985 Immediate central hemodynamic effects of five different beta- adrenoceptor-blocking agents. acebutolol. atenolol, pindolol, practolol and propranolol in patients with ischemic heart disease. Svendsen TL, et al. American Heart Journal 109: 1145, 1985 A double-blind. placebo controlled study of the antianginal effect of ketanserin in patients receiving a beta-adrenoceptor antagonist. Cameron HA. et al. British Journal of Clinical Pharmacology 20: 525P. 1985 Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Findlay IN. et al. British Heart Journal 55: 240. 1986 Comparison of once-daily atenolol and placebo in the treatment of stable angina pectoris. Shapiro W. Cardiovascular Reviews & Reports 6: 129:!. 1985 Comparison of nicardipine hydrochloride and atenolol in stable angina pectoris. Logan R. et al. Australian & New Zealand Journal of Medicine 15: 535. 1985 A double blind randomised comparison of the 24 h anti-anginal activity of celiprolol vs atenolol. Jackson NC. et al. British Journal of Clinical Pharmacology 21: 594P. 1986 The effects of beta blocker, <:alcium antagonist. and nitrate in patients with exertional and rest angina. Quyyumi AA. et al. British Heart Journal 54: 643. 1985 Experimental exercise-induced ischemia. Drug therapy can eliminate regional dysfunction and oxygen supply-demand imbalance. Guth BD. et al. Journal of the American College of Cardiology 7: 1036, 1986 13 Sep 1986 19
-
Upload
truongquynh -
Category
Documents
-
view
223 -
download
4
Transcript of Atenolol: ICI's β-blocker has been approved for marketing in the USA as an antianginal agent
JFrom Our JFUes Atenolol: ICI's p-blocker has been approved for marketing in the USA as an antianginal agent
Therapeutic use Atenolol in the treatment of angina pectoris. Bachmann M. et al.
Schweizerische Medizinische Wochenschrift 109: 1857. 1979 Electrocardiographic ischemic threshold after intravenous
administration of atenolol in patients with angina of effort. Radice M. et al. Acta Therapeutica 5: 305. 1979
Atenolol: once daily cardioselective beta blockade for angina pectoris. Jackson G. et al. Circulation 61: 555. 1980
Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. Thompson DS. et al. British Heart Journal 43: 668. 1980
Once a day p-adrenoccptor blockade in the management of angina pectoris. Joy M. et al. European Journal of Clinical Investigation 10: 17. 1980
Effects of atenolol on heart rate. blood pressure and exercise tolerance in patients with essential hypertension and effort angina. Okamatsu S. et a!. Acta Therapeutica 6: 325. 1980
Long-term benefit of cardioselective p-blockade with once-daily atenolol therapy in angina pectoris. Schwartz JB et al. American Heart Journal 101: 380. 1981
Effect of long-term administration of atenolol on exercise tolerance in patients with angina or effort. Radice M. et al. International Journal of Clinical Pharmacology Research 2: 119, 1982
Action of nifedipine and atenolol administration in patients suffering from essential hypertension and angina pectoris. Schirripa V, et al. Minerva Medica 73: 3191, 1982
Cardioselectivity and Partial Agonist Activity in the Antianginal Efficacy of the ~-Adrenoceptor Antagonists. Magnani B. et al. Drugs 25: 166. 1983
Therapeutic Comparison between atenolol and nifedipine in effort angina. Gruppillo P. et al. Drugs 25: 194. 1983
Atenolol in Angina. Boyle RM. et al. Drugs 25: 193, 1983 A comparison of once and twice daily atenolol for angina pectoris.
Bo) le RM. et al. International Journal of Cardiology 3: 25. 1983 Improved exercise performance following single daily dose of atenolol
in stable angina. Balu V, et al. International Journal of Cardiology 3: 15. 1983
Are 'long-acting nitrates' effective in effort related angina pectoris? O'Neill. D. et al. British Heart Journal49: 619. 1983
Effect of atenolol on treadmill performance in patients with angina pectoris. Kritzer G. et al. Clinical Pharmacy 2: 236. 1983
Combined therapy with verapamil and atenolol in chronic stable angina. Lessem J. Journal of the American College of Cardiology 1: 596. 1983
Atenolol once daily in angina. Makynen P. Ruosteenoja R. V11l World Congress of Cardiology. Tokyo 183. 1978
Atenolol once daily in the treatment of angina pectoris. Majid BA. et al. Vl11 World Congress of Cardiology- Tokyo 182, 1978
The effects of atenolol. given once and twice daily, in patients with angina pectoris. Harry J. et al. V11I World Congress of Cardiology -Tokyo 187. 1978
Effect of atenolol and nitroglycerin ointment on exercise tolerance in patients with coronary heart disease. Koenig W. Diehm C. Deutsche Medizinische Wochenschrift 108: 1798. 1983
The combination of nifedipine and atenolol in angina pectoris. Efficacy and effect on left ventricular function. Findlay I. et al. Circulation 68: 111-53. 1983
The influence of partial agonist activity of beta blockers in treatment of angina pectoris. Quyyumi AA. et al. Circulation 68: 111-54. 1983
Cigarette smoking and the treatment of angina with propranolol. atenolol. and nifedipine. Deanfield J. et al. New England Journal
0156-2703/86/0913-()()19/0$01.00/0 ® ADIS Press
of Medicine 31 0: 951. 1984 Effect of partial agonist activity in beta blockers in severe angina
pectoris: a double blind comparison of pindolol and atenolol. Quyyumi AA. et al. British Medical Journal 289: 951. 1984
1\tenolol. nadolol. and pindolol in angina pectoris on effort: Effect of pharmacokinetics. Kostis JB. et al. American Heart Journal 108: 1131. 1984
Combined therapy with Ca-antagonists and beta adrenergic receptor blocking agents in chronic stable angina. Lessem J. Acta Medica Scandinavica 83. 1984
Addition of verapamil in the treatment of angina resistant to f:Jadrenoceptor blockers. McGourty JC. et al. British Journal of Clinical Pharmacology I 7: 638P. 1984
Partial agonist activity in beta blockers: The importance of heart rate reduction in treatment of nocturnal angina. Quyyumi AA, et al. European Heart Journal 5: 33. 1984
Combination of nifedipine with atenolol or propranolol in chronic stable angina. de Buitleir M. et al. European Heart Journal 5: 128. 1984
Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. Quyyumi AA. et al. British Medical Journal 289: 951, 1984
Synergistic action of molsidomine and athenolol in patients with exertional angina. Gimeno JV. et al. Medicina Clinica 83: 624. 1984
The treatment of angina pectoris in patients with chronic obstructive airways disease. Findlay IN. et al. British Journal of Clinical Pharmacology 19: I SOP. 1985
Double-blind. randomised. placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol. De Backer GG. Derese A. American Heart Journal 109: 6 78. 1985
Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris. Jee LD. Opie LH. American Journal of Cardiology 56: 551, 1985
Comparison of oxyfedrine and atenolol in angina pectoris - a doubleblind study. Fananapazir L. Bray C. British Journal of Clinical Pharmacology 20: 405. 1985
Immediate central hemodynamic effects of five different betaadrenoceptor-blocking agents. acebutolol. atenolol, pindolol, practolol and propranolol in patients with ischemic heart disease. Svendsen TL, et al. American Heart Journal 109: 1145, 1985
A double-blind. placebo controlled study of the antianginal effect of ketanserin in patients receiving a beta-adrenoceptor antagonist. Cameron HA. et al. British Journal of Clinical Pharmacology 20: 525P. 1985
Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Findlay IN. et al. British Heart Journal 55: 240. 1986
Comparison of once-daily atenolol and placebo in the treatment of stable angina pectoris. Shapiro W. Cardiovascular Reviews & Reports 6: 129:!. 1985
Comparison of nicardipine hydrochloride and atenolol in stable angina pectoris. Logan R. et al. Australian & New Zealand Journal of Medicine 15: 535. 1985
A double blind randomised comparison of the 24 h anti-anginal activity of celiprolol vs atenolol. Jackson NC. et al. British Journal of Clinical Pharmacology 21: 594P. 1986
The effects of beta blocker, <:alcium antagonist. and nitrate in patients with exertional and rest angina. Quyyumi AA. et al. British Heart Journal 54: 643. 1985
Experimental exercise-induced ischemia. Drug therapy can eliminate regional dysfunction and oxygen supply-demand imbalance. Guth BD. et al. Journal of the American College of Cardiology 7: 1036, 1986
/NPHARMA~ 13 Sep 1986 19
